Description
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Cas No. | 1610358-56-9 |
|---|---|
| Purity | ≥98% |
| Formula | C19H18F2N4O2S |
| Formula Wt. | 404.44 |
| IUPAC Name | 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]-2-pyridinyl}-2-pyridinamine |
| Synonym | BAY 1251152, BAY1251152 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Luecking U., Scholz A., et al. Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. Cancer Res. 77(13 Suppl):Abstract nr 984 (2017).
PLK1 inhibitor.
MAO and histone demethylase LSD1 inhibitor.
Mycotoxin produced by Aspergillus; BK K+ channe...
BRD inhibitor.
IGF-1R and InsR inhibitor.
Synephrine is an endogenous alkaloid.
Benzisoxazole phenylethanone; D2 and 5-HT2A ant...
A fungal metabolite that inhibits protein synth...
Pyrimidine nucleoside base, pairs with adenosin...
MET inhibitor.
Sesquiterpene lactone derived from Artemesia; m...
CB2 receptor antagonist.
Polyene macrolide; ergosterol inhibitor.
Aromatic retinoid; RAR, RXR agonist.
L-type Ca2+ channel blocker.
Synthetic ITC.
Active form of vitamin D, regulates dietary Ca2...
Dihydropyridine; L-type and T-type Ca2+ channel...
SK K+ channel blocker, EGFR inhibitor.
Expectorant.